Company: QXO-PB
Filing Date: 2025-03-17
Form Type: 8-K
Source: 0000950142-25-000763
Chunk: 3

Company: QXO, Inc.
Filing Date: 2025-03-17
Form: 8-K
Item: Item 8.01
Chunk 3
---
�───────────────────────────────────────────────────────────────────────────────────────────────────────────────────────────────────────

  the possibility that an active, liquid trading market for the Company’s common stock may not be sustained;  
 ──────────────────────────────────────────────────────────────────────────────────────────────────────────────

  the possibility that the Company’s outstanding warrants and preferred stock may or may not be converted or exercised, and the           
  economic impact on the Company and the holders of common stock of the Company that may result from either such exercise or conversion,  
  including dilution, or the continuance of the preferred stock remaining outstanding, and the impact its terms, including its dividend,  
  may have on the Company and the common stock of the Company;                                                                            
 ──────────────────────────────────────────────────────────────────────────────────────────────────────────────────────────────────────────

  uncertainties regarding the Company’s focus, strategic plans and other management actions;  

  the risk that the Company is or becomes highly dependent on the continued leadership of Brad Jacobs as chairman and chief executive  

  the possibility that the concentration of ownership by Jacobs may have the effect of delaying or preventing a change in control of  
  the Company and might affect the market price of shares of the common stock of the Company;                                         
 ──────────────────────────────────────────────────────────────────────────────────────────────────────────────────────────────────────

  the risk that Jacobs’ past performance may not be representative of future results;  
 ───────────────────────────────────────────────────────────────────────────────────────

  the risk that the Company is unable to attract and retain world-class talent;  

  the risk that the failure to consummate any acquisition expeditiously, or at all, could have a material adverse effect on the Company's  

  risks that the Company may not be able to enter into agreements with acquisition targets on attractive terms, or at all, that agreed     
  acquisitions may not be consummated, or, if consummated, that the anticipated benefits thereof may not be realized and that the Company  
  encounter difficulties in integrating and operating such acquired companies, or that matters related to an acquired business             
 ───────────────────────────────────────────────────────────────────────────────────────────────────────────────────────────────────────────

   3  

  (including                                                                                                                              
  operating results or liabilities or contingencies) may have a negative effect on the Company or its securities or ability to implement  
  its business strategy, including that any such transaction may be dilutive or have other negative consequences